Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Info & Links
CEO
Dolev Rafaeli
Headquarters
5 WALNUT GROVE DRIVE,SUITE 140 HORSHAM, PA 19044, UNITED STATES
Strata Skin Sciences, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
11.22M
Enterprise Value
17.98M
Enterprise Value/EBITDA(ttm)
-6.06
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
0.37
Price to Book(mrq)
1.28
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
54.93%
Operating Margin(ttm)
-21.73%
Profit Margin(ttm)
-29.71%
Return on Equity(ttm)
-69.33%
Return on Invested Capital(ttm)
-36.49%
Return on Assets(ttm)
-17.55%
Income Statement
Revenue(ttm)
32.67M
Revenue Per Share(ttm)
7.83
Gross Profit(ttm)
18.13M
EBITDA(ttm)3
-2.97M
Net Income Available to Common(ttm)
-9.38M
Diluted EPS(ttm)
-2.66
Share Statistics
Beta (5Y Monthly)
1.33
52-Week Change
-42.81%
S&P 500 52-Week Change
18.21%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
4.17M
Dividend Yield
0.00%
Float4
2.54M
% Held by Insiders
39.00%
% Held by Institutions
32.43%
Balance Sheet
Total Cash(mrq)
8.40M
Total Cash Per Share(mrq)
2.01
Total Debt(mrq)
15.15M
Total Debt/Equity(mrq)
162.19%
Current Ratio(mrq)
1.13%
Quick Ratio(mrq)
0.94%
Book Value Per Share(mrq)
2.24
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.13
Free Cash Flow(ytd)
-1.65M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.